Sequana Medical NV (SEQUA BR) stock market data APIs
€0.9495
0.02(2.1%)
as of May 23, 2025
Try our APIs with
free plan!
Sequana Medical NV Financial Data Overview
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Prev. Close
0.9495
Open
0.9713
High
0.9899
Low
0.9143
52 wk Range
0.471-4.39
Market Cap
51 500 K
Shares Outstanding
54 671 K
Revenue
106 K
Beta
-0.052
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sequana Medical NV data using free add-ons & libraries
Get Sequana Medical NV Fundamental Data
Sequana Medical NV Fundamental data includes:
- Net Revenue: 106 K
- EBITDA: -18 405 128
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-23
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sequana Medical NV News
New
Sequana Medical announces 2021 Full Year Results and 2022 Outlook
alfapump®in liver disease Positive results from second interim analysis of POSEIDON pivotal study; encouraging survival data at 12 months vs. published literaturePatient enrolment and implants compl...
Sequana Medical announces 2021 Full Year Results and 2022 Outlook
Sequana Medical alfapump®in liver disease Positive results from second interim analysis of POSEIDON pivotal study; encouraging survival data at 12 months vs. published literature Patient enrolment ...
Sequana Medical to present at Needham’s Healthcare Conference and attend Kempen’s Life Sciences Conference in April 2022
GHENT, Belgium, April 08, 2022 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), an innovator in the treatment of diuretic-resistant fluid overlo...
Sequana Medical to present at Needham’s Healthcare Conference and attend Kempen’s Life Sciences Conference in April 2022
Sequana Medical GHENT, Belgium, April 08, 2022 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), an innovator in the treatment of diuretic-resista...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
